Abstract
Angiotensin converting enzyme (ACE)-inhibitory drugs have been used as therapeutic tools in the clinical management of hypertension and associated cardiovascular disorders. Food-derived ACE-inhibitory peptides have lower potency than similar acting drugs but the peptides usually have no adverse side effects and there is virtually no risk of overdosing that is associated with drugs. This review summarizes several patents that have reported the development of technologies for the production of potent food protein-derived hydrolysates and peptides, which can be used to formulate antihypertensive functional foods and nutraceuticals. A common process to all the patents is the use of proteases to split large inactive proteins into smaller bioactive peptides. Ultrafiltration may be combined with liquid chromatography methods to separate the peptides according to size alone or a combination of size and charge density, respectively. Efficacy of the protein hydrolysates or peptide fractions is evaluated first in an in vitro system and may then be confirmed by measuring their hypotensive ability in an appropriate animal model such as the spontaneously hypertensive rats. Finally, protein hydrolysates or peptide fractions that have hypotensive ability may then be used to formulate foods, beverages or pills that can be taken as therapeutic tools against hypertension.
Keywords: Bioactive peptides, angiotensin converting enzyme, antihypertensive, food proteins, membrane ultrafiltration, protein hydrolysate, spontaneously hypertensive rats
Recent Patents on Biotechnology
Title: Technology for the Production and Utilization of Food Protein-Derived Antihypertensive Peptides: A Review
Volume: 1 Issue: 3
Author(s): Rotimi E. Aluko
Affiliation:
Keywords: Bioactive peptides, angiotensin converting enzyme, antihypertensive, food proteins, membrane ultrafiltration, protein hydrolysate, spontaneously hypertensive rats
Abstract: Angiotensin converting enzyme (ACE)-inhibitory drugs have been used as therapeutic tools in the clinical management of hypertension and associated cardiovascular disorders. Food-derived ACE-inhibitory peptides have lower potency than similar acting drugs but the peptides usually have no adverse side effects and there is virtually no risk of overdosing that is associated with drugs. This review summarizes several patents that have reported the development of technologies for the production of potent food protein-derived hydrolysates and peptides, which can be used to formulate antihypertensive functional foods and nutraceuticals. A common process to all the patents is the use of proteases to split large inactive proteins into smaller bioactive peptides. Ultrafiltration may be combined with liquid chromatography methods to separate the peptides according to size alone or a combination of size and charge density, respectively. Efficacy of the protein hydrolysates or peptide fractions is evaluated first in an in vitro system and may then be confirmed by measuring their hypotensive ability in an appropriate animal model such as the spontaneously hypertensive rats. Finally, protein hydrolysates or peptide fractions that have hypotensive ability may then be used to formulate foods, beverages or pills that can be taken as therapeutic tools against hypertension.
Export Options
About this article
Cite this article as:
Aluko E. Rotimi, Technology for the Production and Utilization of Food Protein-Derived Antihypertensive Peptides: A Review, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330129
DOI https://dx.doi.org/10.2174/187220807782330129 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal The Emerging Role of Helicobacter Pylori-Induced Metabolic Gastrointestinal Dysmotility and Neurodegeneration
Current Molecular Medicine Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Myogenic Properties of Brain and Cardiac Vessels and their Relation to Disease
Current Vascular Pharmacology Acute Severe Arterial Hypertension: Therapeutic Options
Current Drug Targets Angiotensin Receptor Blockers in Chronic Heart Failure: Clinical Implications and Molecular Mechanisms
Current Cardiology Reviews Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Current Diabetes Reviews Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal Ethosomes as Novel Vesicular Carrier: An Overview of the Principle, Preparation and its Applications
Current Drug Delivery The Validity of Chemical Analytical Methods by the Example of the Heparin Product Recall
Current Pharmaceutical Analysis Synthesis of 4-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-(substituted phenyl)pyrimidin-2-ol Analogues as Anti-Inflammatory and Analgesic Agents
Letters in Drug Design & Discovery Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design A Fatal Case of Acute Interstitial Pneumonia (AIP) in a Woman Affected by Glioblastoma
Current Drug Safety Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies Catheter-directed Thrombolysis <i>versus</i> Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis
Current Cardiology Reviews Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases
Current Pharmaceutical Design Aquaretic Agents: Whats Beyond the Treatment of Hyponatremia?
Current Pharmaceutical Design Diabetic Gastroenteropathy: Soothe the Symptoms or Unravel a Cure?
Current Diabetes Reviews